- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sonoma Pharmaceuticals Inc (SNOA)
Sonoma Pharmaceuticals Inc stock price live, this page displays NASDAQ SNOA stock exchange data. View the SNOA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sonoma Pharmaceuticals Inc real time stock price chart below.
What Is the Sonoma Pharmaceuticals Inc Stock Price Today?
The Sonoma Pharmaceuticals Inc stock price today is 1.150.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc?
The stock symbol for Sonoma Pharmaceuticals Inc is "SNOA."
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNOA quote. (ISIN: US83558L3033)
What Is the Sonoma Pharmaceuticals Inc Stock Price Today?
The Sonoma Pharmaceuticals Inc stock price today is 1.150.
What Is the Stock Symbol for Sonoma Pharmaceuticals Inc?
The stock symbol for Sonoma Pharmaceuticals Inc is "SNOA."
What Stock Exchange Does Sonoma Pharmaceuticals Inc Trade On?
Sonoma Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Sonoma Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Sonoma Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SNOA quote. (ISIN: US83558L3033)
1.150
-0.010(-0.86%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.120
1.150
52 wk Range
0.850
4.250
SNOA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1201.150
52 wk Range
0.8504.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SNOA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July- Investing.com
Form 8K Sonoma Pharmaceuticals Inc For: 19 August- Investing.com
Form 4 Sonoma Pharmaceuticals Inc For: 9 July- Investing.com
- Form 8K Sonoma Pharmaceuticals Inc For: 19 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
Aug 06, 2026
EPS / Forecast
-0.09 / -0.30
Revenue / Forecast
6.4M / 4.99M
Compare SNOA to Peers and Sector
Metrics to compare | SNOA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNOAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | 17.0x | −0.3x | |
PEG Ratio | −0.04 | −0.74 | 0.00 | |
Price/Book | 0.8x | 3.2x | 2.6x | |
Price / LTM Sales | 0.3x | 2.3x | 2.9x | |
Upside (Analyst Target) | - | 29.8% | 64.3% | |
Fair Value Upside | Unlock | 8.5% | 10.0% | Unlock |
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sonoma Pharmaceuticals (SNOA) Stock Price Today?
The Sonoma Pharmaceuticals stock price today is 1.150 USD.
What Stock Exchange Does Sonoma Pharmaceuticals Trade On?
Sonoma Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Sonoma Pharmaceuticals?
The stock symbol for Sonoma Pharmaceuticals is "SNOA."
What Is the Sonoma Pharmaceuticals Market Cap?
As of today, Sonoma Pharmaceuticals market cap is 5.510M USD.
What Is Sonoma Pharmaceuticals's Earnings Per Share (TTM)?
The Sonoma Pharmaceuticals EPS (TTM) is -1.01.
When Is the Next Sonoma Pharmaceuticals Earnings Date?
Sonoma Pharmaceuticals will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is SNOA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sonoma Pharmaceuticals Stock Split?
Sonoma Pharmaceuticals has split 4 times.
How Many Employees Does Sonoma Pharmaceuticals Have?
Sonoma Pharmaceuticals has 10 employees.
What is the current trading status of Sonoma Pharmaceuticals (SNOA)?
As of Oct 15, 2026, Sonoma Pharmaceuticals (SNOA) is trading at a price of 1.150 USD, with a previous close of 1.160 USD. The stock has fluctuated within a day range of 1.120 USD to 1.150 USD, while its 52-week range spans from 0.850 USD to 4.250 USD.
What Is the SNOA After Hours Price?
SNOA's last after hours stock price is 1.150 USD, the stock has decreased by -0.010, or -0.860%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.